Is amnioinfusion beneficial for neonates after preterm premature rupture of membranes (PPROM)?
Christian Orji, Ron Brimberry, Lois Coulter, Jonell S. Hudson
Abstract
Christian Orji, Ron Brimberry, Lois Coulter, Jonell S. Hudson
Abstract
Evidence-Based Answer Transcervical amnioinfusion (TCA) does not appear to improve clinical outcomes in PPROM (SOR: A, systematic review). Transabdominal amnioinfusion (TA) may reduce the risk of neonatal sepsis, pulmonary hypoplasia, and neonatal death, but the evidence is conflicting (no SOR given).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Evidence-Based Answer Transcervical amnioinfusion (TCA) does not appear to improve clinical outcomes in PPROM (SOR: A, systematic review). Transabdominal amnioinfusion (TA) may reduce the risk of neonatal sepsis, pulmonary hypoplasia, and neonatal death, but the evidence is conflicting (no SOR given).
Key concepts: Amnioinfusion, Pulmonary hypoplasia, Medicine, Premature rupture of membranes, Neonatal sepsis, Sepsis, Obstetrics, Oligohydramnios